C-myc/p53 interaction determines sensitivity of human colon carcinoma cells to 5-fluorouracil in vitro and in vivo

Cancer Research

Volumn 61, Issue 12, 2001, Pages 4910-4915

  Arango, Diego ^a   Corner, Georgia A ^a   Wadler, Scott ^a   Catalano, Paul J ^b   Augenlicht, Leonard H ^a  

^a MONTEFIORE MEDICAL CENTER   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; PROTEIN P53;

ARTICLE; COLON CARCINOMA; CONTROLLED STUDY; DRUG SENSITIVITY; GENE ACTIVATION; GENE AMPLIFICATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE;

ANTIMETABOLITES, ANTINEOPLASTIC; APOPTOSIS; CELL DIVISION; CHEMOTHERAPY, ADJUVANT; CLINICAL TRIALS, PHASE III; COLONIC NEOPLASMS; FLUOROURACIL; GENE AMPLIFICATION; GENES, MYC; GENES, P53; HUMANS; MULTICENTER STUDIES; MUTATION; PARAFFIN EMBEDDING; PROTO-ONCOGENE PROTEINS C-MYC; TRANS-ACTIVATION (GENETICS); TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0035874884     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Amplification and elevated expression of c-myc in a chemically induced mouse colon tumor
2. Deregulation of c-myc gene expression in human colon carcinoma is not accompanied by amplification or rearrangement of the gene
3. Down-regulation of β-catenin by human axin and its association with the APC tumor suppressor, β-catenin and GSK3 β
4. Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC
5. Identification of c-MYC as a target of the APC pathway
6. β-Catenin regulates expression of cyclin D1 in colon carcinoma cells
7. Aggressive subtypes of human colorectal tumors frequently exhibit amplification of the c-myc gene
8. Low-level c-myc amplification in human colonic carcinoma cell lines and tumors: A frequent, p53-independent mutation associated with improved outcome in a randomized multi-institutional trial
9. Induction of apoptosis in fibroblasts by c-myc protein
10. p53 mediates apoptosis induced by c-Myc activation in hypoxic or γ-irradiated fibroblasts
11. Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis
12. Apoptosis-prone phenotype of human colon carcinoma cells with a high level amplification of the c-myc gene
13. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo
14. Overexpression of the wild-type p53 gene inhibits NF-κB activity and synergizes with aspirin to induce apoptosis in human colon cancer cells
15. Induction of Fas-mediated apoptosis in p53-transfected human colon carcinoma cells
16. p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs
17. Disruption of p53 in human cancer cells alters the responses to therapeutic agents
18. Wild-type p53 protein potentiates cytotoxicity of therapeutic agents in human colon cancer cells
19. Deregulated BCL2 expression enhances growth of a human B cell line
20. Chimaeras of myc oncoprotein and steroid receptors cause hormone-dependent transformation of cells
21. Translocation and rearrangements of the c-myc oncogene locus in human undifferentiated B-cell lymphomas
22. Myc and Max proteins possess distinct transcriptional activities
23. New colorimetric cytotoxicity assay for anticancer-drug screening
24. Divergent phenotypic patterns and commitment to apoptosis of Caco-2 cells during spontaneous and butyrate-induced differentiation
25. Short-chain fatty acid-initiated cell cycle arrest and apoptosis of colonic epithelial cells is linked to mitochondrial function
26. A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy
27. 1 arrest and induces apoptosis in human cancer cells
28. Mutational analysis of the APC/β-catenin/Tcf pathway in colorectal cancer
29. Axin, a negative regulator of the wnt signaling pathway, directly interacts with adenomatous polyposis coli and regulates the stabilization of β-catenin
30. How a growth control path takes a wrong turn to cancer